Navigation Links
All-Oral Combination Study with PSI-7977 for HCV Genotypes 1, 2 and 3 Initiated
Date:5/26/2011

Act of 1995: Statements in this press release that are not historical facts are "forward-looking statements," that involve risks, uncertainties, and other important factors, including, without limitation, the risk of cessation or delay of any of the ongoing or planned clinical trials and/or our development of our product candidates, the risk that the results of previously conducted studies involving our product candidates will not be repeated or observed in ongoing or future studies involving our product candidates, the risk that our collaboration with Roche will not continue or will not be successful, and the risk that any one or more of our product candidates will not be successfully developed and commercialized. For a discussion of risks, uncertainties, and other important factors, any of which could cause our actual results to differ from those contained in the forward-looking statements, see the section entitled "Risk Factors" in our Annual Report on Form 10-K for the fiscal year ended September 30, 2010 and our Quarterly Reports on Form 10-Q filed with the Securities and Exchange Commission and discussions of potential risks, uncertainties, and other important factors in our subsequent filings with the Securities and Exchange Commission.


'/>"/>
SOURCE Pharmasset, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine technology :

1. Ground-Breaking Combination of All-Oral Agents Demonstrates Potential as Hepatitis C Treatment Regimen
2. Ardea Biosciences Provides Additional Results From a Phase 2b Study of Lesinurad in Combination With Allopurinol at the Annual European Congress of Rheumatology
3. Nexavar in Combination with Chemotherapy Improves Progression-Free Survival in Patients with Advanced Breast Cancer in Phase 2 Study
4. ViroPharma and Halozyme Announce Collaboration for Combination of Recombinant Human Hyaluronidase Enzyme (rHuPH20) Technology with C1 Esterase Inhibitor
5. Pearl Therapeutics Highlights Its Porous Particle Cosuspension Platform, Demonstrating Universal Applicability Across Multiple Drug Classes and Combination Products
6. Particle Sciences and Celanese EVA Performance Polymers Collaborate to Accelerate Drug-Eluting Device Combinations
7. Jennerex and Green Cross Announce Publication of Positive Clinical Data of JX-594 in Combination With Sorafenib in Advanced Liver Cancer
8. Merrimack Pharmaceuticals Announces that Recruitment is Open in a Phase 1 Combination Study of MM-111 with Multiple Treatment Regimens in HER2 Positive Patients
9. New Interim Data About Combination Oral Contraceptives
10. Syndax Announces Start of NCI Sponsored Phase 2 Study of Entinostat in Combination in Triple Negative Breast Cancer
11. Bayer and Onyx Begin Enrollment in Phase 3 Trial of Nexavar in Combination With Chemotherapy Agent Capecitabine for Patients With Advanced Breast Cancer
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/15/2014)... 2014  Decision Resources Group,s new Manhattan ... that online information and other value-added services ... their offering and support physicians. Physicians who ... rely on websites, mobile apps and other ... physicians are looking to manufacturers to provide ...
(Date:9/15/2014)... , Sept. 15, 2014 myMatrixx has extended ... Stanos with an expanded role that includes direct ... Dr. Stanos, a nationally recognized physiatrist and pain management ... to rehabilitation and workers, compensation, is Board Certified in ... American Board of Pain Medicine and subspecialty boarded by ...
(Date:9/15/2014)... Sept. 15, 2014  Catalist-listed QT Vascular Ltd. ("QT ... developer and manufacturer of minimally invasive medical devices for ... that the Group has enrolled the first European patients ... . Multiple patients have already been enrolled in this ... City Hospital, in Auckland, New Zealand ...
Breaking Medicine Technology:Physician device decision-makers show strong demand for device manufacturer digital content and support 2Physician device decision-makers show strong demand for device manufacturer digital content and support 3myMatrixx Announces Expanded Role for Medical Director Steven P. Stanos, Jr., DO 2First European Patients Enrolled in QT Vascular's ENDURE Trial 2First European Patients Enrolled in QT Vascular's ENDURE Trial 3First European Patients Enrolled in QT Vascular's ENDURE Trial 4First European Patients Enrolled in QT Vascular's ENDURE Trial 5
... , SACRAMENTO, Calif., Nov. 10 The Joint ... Ventricular Assist Device/Destination Therapy certification, allowing the Sacramento ... ventricular assist devices (LVADs) as permanent therapy and ... Medical Center, Sacramento is the only hospital in ...
... Stryker Corporation (NYSE: SYK ) announced today that ... technology firm. OtisMed will focus on customizable instrumentation ... that surgeons and patients realize from Stryker,s Triathlon Knee ... operate as part of Stryker,s Orthopaedics Division and remain ...
Cached Medicine Technology:Sutter Medical Center Receives Certification to Use Ventricular Assist Devices as Destination Therapy 2Stryker Announces Agreements To Acquire Assets 2Stryker Announces Agreements To Acquire Assets 3
(Date:9/15/2014)... 2014 Octo Consulting Group, a ... to the federal government, today announced it is ... Atlanta, Georgia to better serve existing and future ... is credited to the strong growth momentum of ... of management consulting, agile software development, data visualization, ...
(Date:9/15/2014)... By Randy Dotinga ... (HealthDay News) -- Patients prescribed cholesterol-lowering drugs are more ... if the medications are cheaper generic brands, new research ... as statins. Well-known brands include Crestor, Zocor and Lipitor. ... to lower the risk of heart problems due to ...
(Date:9/15/2014)... approximately one out of every 40 individuals in the United ... muscular atrophy (SMA), a neurodegenerative disease that causes muscles to ... have made a recent breakthrough with the development of a ... of the disease. In April, a patent was filed for ... lab is using to fight SMA is to ,repress the ...
(Date:9/15/2014)... Texas (PRWEB) September 16, 2014 ... key market data on the Canada Gynecological Devices ... US dollars, volume (in units) and average prices ... Female Sterilization Devices (Transcervical Sterilization ... and Rings) , Endometrial Ablation Devices ...
(Date:9/15/2014)... September 15, 2014 In order to ... medicine often act conjointly to quantify, define and model ... become an integral part of medical care. , The ... the studies conducted by the non-profit Institute of BioAcoustic ... demonstrated that math can be much more than a ...
Breaking Medicine News(10 mins):Health News:Octo Consulting Group Announces it is Opening Two New Offices in Alexandria, Virginia and Atlanta, Georgia to Better Serve Existing and Future Federal Government Clients 2Health News:Older Patients More Likely to Fill Prescriptions for Generic Statins: Study 2Health News:Older Patients More Likely to Fill Prescriptions for Generic Statins: Study 3Health News:Researcher develops and proves effectiveness of new drug for spinal muscular atrophy 2Health News:Canada Gynecological Devices Market Outlook to 2020 in New Report Available at MarketOptimizer.org 2Health News:Canada Gynecological Devices Market Outlook to 2020 in New Report Available at MarketOptimizer.org 3Health News:Canada Gynecological Devices Market Outlook to 2020 in New Report Available at MarketOptimizer.org 4Health News:Math as Medicine: The Promise of Frequency Domain BioMarkers as a Template to Predict, Enchance and Promote Optimal Health 2Health News:Math as Medicine: The Promise of Frequency Domain BioMarkers as a Template to Predict, Enchance and Promote Optimal Health 3
... Video game makers are now looking to extend their reach beyond ... a really ripe market awaits them. For the aging population in ... water.// ,Leading games manufacturer, Nintendo has sold 3.3 million ... May last. "We wanted to reach out to those who were ...
... uses the construction abilities of tiny viruses to build ... batteries.// , MIT Professors Angela Belcher, Paula ... few genes within common laboratory virus strains were able ... functional electronic device. ,Batteries are made of ...
... Emirates are concerned with the proposal of the Ministry of ... the country.// ,"A committee has been set up ... provides for the private medical sector. This includes the licensing ... and the licensing of the medical or health establishments as ...
... Pink is angry that teenage girls are so obsessed with ... a sex tape.// ,According to contactmusic.com, Pink caused controversy ... in her song "Stupid Girls". But she says there is ... the popularity of Hilton's raunchy homemade film made with her ...
... Association, Les Woolard of Moree says that the Federal Government ... prepared to work in regional areas. // ,According to ... who live in Newcastle, Sydney and Wollongong there are six ... there is only one psychologist. ,He said that ...
... obesity is that the amount of junk food youngsters ... spend// watching television. Researchers analyzed the dietary and viewing habits ... , It was found that consumption of sweets and fizzy ... the idiot box. Researchers at the universities of Aberdeen and ...
Cached Medicine News:Health News:TV Viewing Increases Intake of Junk Food 2
... vascular closure device quickly seals ... procedures, allowing for early ambulation ... creates a mechanical seal by ... bio-absorbable anchor and collagen sponge, ...
These are coronary angiographic catheters used for selective coronary bypass angiography. The catheters curve configuration is ideally suited to select the internal mammary artery....
Femoral selective catheter. Catheter material used is polyurethane (DUCOR). Guidewire campatibility is 0.038". Packaging 5/Box....
Femoral selective diagnostic catheter. The material used is nylon (VESTANTM). All selective shapes have thrulumen design. Guidewire campatibility is 0.038". Packaging 5/Box....
Medicine Products: